ArticleFrontiers in pharmacology2025

Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis.

Long He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.